Abstract
With its fiscal year 2003 budget approaching $4 billion, the National Institute of Allergy and Infectious Diseases (NIAID) represents the second largest of the institutes constituting the National Institutes of Health’s (NIH) “big three.” Although the institute does not represent a major source of research funding support for the house of radiology, its importance to national and global medicine, public health, and more recently biodefense warrants its inclusion for discussion in this series.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
